Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Trigeminal neuralgia: therapeutic strategies to restore quality of life
1Aragon Dental Clinic, Faculty of Higher Studies Iztacala, National Autonomous University of Mexico, 057130 Nezahualcóyotl, EM, Mexico
2Research Laboratory in Dental Education, Dental Surgeon Career, FES Iztacala, UNAM, 54090 Tlalnepantla, EM, Mexico
3Almaraz Dental Research Laboratory, Dental Surgeon Career, FES Iztacala, UNAM, 54714 Cuautitlán Izcalli, EM, Mexico
DOI: 10.22514/jofph.2024.024 Vol.38,Issue 3,September 2024 pp.32-37
Submitted: 28 April 2024 Accepted: 13 June 2024
Published: 12 September 2024
*Corresponding Author(s): Alejandro García Muñoz E-mail: alexandro_06@iztacala.unam.mx
Trigeminal neuralgia (TN) usually affects the maxillary and mandibular branches of the fifth cranial nerve. Although the condition is primarily unilateral, few cases of bilateral manifestation have been reported. TN is uncommon; however, it significantly affects patients’ quality of life because the neuropathic pain worsens over time. Paroxysmal pain is triggered by mechanical stimuli or environmental factors. Diagnosis is usually based on clinical findings, including pain triggered by palpation of distinct areas; nevertheless, imaging studies, such as magnetic resonance imaging, are always used to rule out a secondary cause. TN can be caused by several factors, such as trauma and neurovascular compression, or could be idiopathic, which complicates its treatment. Although several studies focused on TN have been reported, a treatment modality with 100% efficacy is lacking. The first-line treatment is pharmacological; however, surgery may be required if symptoms persist.
Trigeminal neuralgia treatment; Facial pain; Diagnosis; Neuropathic pain; Surgical treatment; Neuralgia; Epidemiology; Dental pain
Diego Villegas Díaz,Gabriela Guerrero Alvarado,Alan López Medina,José Francisco Gómez Clavel,Alejandro García Muñoz. Trigeminal neuralgia: therapeutic strategies to restore quality of life. Journal of Oral & Facial Pain and Headache. 2024. 38(3);32-37.
[1] Kumar S, Rastogi S, Kumar S, Mahendra P, Bansal M, Chandra L. Pain in trigeminal neuralgia: neurophysiology and measurement: a comprehensive review. Journal of Medicine and Life. 2013; 6: 383–388.
[2] Chakraborty AR, Sunshine K, Miller JP, Sweet JA. Current applications of ablative therapies for trigeminal neuralgia. Neurosurgery Clinics of North America. 2023; 34: 285–290.
[3] Gietzen L. Trigeminal neuralgia. Journal of the American Academy of Physician Assistants. 2017; 30: 46–47.
[4] Obermann M, Katsarava Z. Update on trigeminal neuralgia. Expert Review of Neurotherapeutics. 2009; 9: 323–329.
[5] Houshi S, Tavallaei MJ, Barzegar M, Afshari-Safavi A, Vaheb S, Mirmosayyeb O, et al. Prevalence of trigeminal neuralgia in multiple sclerosis: a systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. 2022; 57: 103472.
[6] Maarbjerg S, Di Stefano G, Bendtsen L, Cruccu G. Trigeminal neuralgia—Diagnosis and treatment. Cephalalgia. 2017; 37: 648–657.
[7] Voormolen JHC. Treatment for trigeminal neuralgia. Archives of Physiology and Biochemistry. 1998; 106: 335–337.
[8] Z Zeng C, Zhang C, Li YH, Feng X, Zhang MJ, Xiao RH, et al. Recent advances of magnetic resonance neuroimaging in trigeminal neuralgia. Current Pain and Headache Reports. 2021; 25: 37.
[9] Cruccu G, Finnerup NB, Jensen TS, Scholz J, Sindou M, Svensson P, et al. Trigeminal neuralgia: new classification and diagnostic grading for practice and research. Neurology. 2016; 87: 220–228.
[10] Gusmão S, Magaldi M, Arantes A. Trigeminal radiofrequency rhizotomy for the treatment of trigeminal neuralgia: results and technical modification. Arquivos de neuro-psiquiatria. 2003; 61: 434–440.
[11] Joshi D, Gyanpuri V, Pathak A, Chaurasia RN, Mishra VN, Kumar A, et al. Neuropathic pain associated with COVID-19: a systematic review of case reports. Current Pain and Headache Reports. 2022; 26: 595-603.
[12] Bendtsen L, Zakrzewska JM, Heinskou TB, Hodaie M, Leal PRL, Nurmikko T, et al. Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia. Lancet Neurology. 2020; 19: 784–796.
[13] Zakrzewska JM, Linskey ME. Trigeminal neuralgia. BMJ Clinical Evidence. 2014; 6: 1207.
[14] May A, Hoffmann J. Facial pain beyond trigeminal neuralgia. Current Opinion in Neurology. 2021; 34: 373–377.
[15] Busch RL. The Treatnent of Trigeminal Neuralgia; Anesthesia Progress. 1987; 34: 199–201.
[16] Falaki F, Nejat AH, Dalirsani Z. The effect of low-level laser therapy on trigeminal neuralgia: a review of literature. Journal of Dental Research Dental Clinics Dental Prospects. 2014; 8: 1–5.
[17] Gambeta E, Chichorro JG, Zamponi GW. Trigeminal neuralgia: an overview from pathophysiology to pharmacological treatments. Molecular Pain. 2020; 16: 1744806920901890.
[18] Bendtsen L, Zakrzewska JM, Abbott J, Braschinsky M, Di Stefano G, Donnet A, et al. European Academy of Neurology guideline on trigeminal neuralgia. European Journal of Neurology. 2019; 26: 831–849.
[19] Latorre G, González-García N, García-Ull J, González-Oria C, Porta-Etessam J, Molina FJ, et al. Diagnosis and treatment of trigeminal neuralgia: consensus statement from the Spanish society of neurology’s headache study group. Neurología. 2023; 38: S37–S52.
[20] Boto GR. Trigeminal neuralgia. Neurología. 2010; 21: 361–372.
[21] Lettmaier S. Radiosurgery in trigeminal neuralgia. Physica Medica. 2014; 30: 592–595.
[22] Molina-Olier O, Marsiglia-Pérez D, Alvis-Miranda H. Surgical treatment of trigeminal neuralgia in adults. Cirugia y Cirujanos. 2022; 90: 548–555.
[23] Leclercq D, Thiebaut JB, Héran F. Trigeminal neuralgia. Diagnostic and Interventional Imaging. 2013; 94: 993–1001.
[24] Alizadeh Y, Hayak H, Khoshnevisan A. Microvascular decompression versus gamma knife surgery in patients with drug-resistant trigeminal neuralgia: a systematic review and meta-analysis. World Neurosurgery. 2022; 167: 67–73.
[25] Ang L, Kim H-J, Heo J-W, Choi, T-Y, Lee HW, et al. Acupuncture for the treatment of trigeminal neuralgia: a systematic review and meta-analysis. Complementary Therapies in Clinical Practice. 2023; 52: 101763.
[26] Morra ME, Elgebaly A, Elmaraezy A, Khalil AM, Altibi AMA, Vu TL-H, et al. Therapeutic efficacy and safety of botulinum toxin a therapy in trigeminal neuralgia: a systematic review and meta-analysis of randomized controlled trials. The Journal of Headache and Pain. 2016; 17: 63.
[27] López J. Cirugía oral y maxilofacial: atlas de procedimientos y técnicas quirúrgicas.1st edn. Editorial Médica Panamericana: México. 2019. (In Spanish).
[28] Pérez D, Ruiz G, Valdez G. Efectividad del láser terapéutico en padecimientos con dolor orofacial. Avances En Odontoestomatología. 2018; 34: 87–93. (In Spanish).
[29] Ebrahimi H, Najafi S, Khayamzadeh M, Zahedi A, Mahdavi A. Therapeutic and analgesic efficacy of laser in conjunction with pharmaceutical therapy for trigeminal neuralgia. Journal of Lasers in Medical Sciences. 2018; 9: 63–68.
[30] Amanat D, Ebrahimi H, Lavaee F, Alipour A. The adjunct therapeutic effect of lasers with medication in the management of orofacial pain: double blind randomized controlled trial. Photomedicine and Laser Surgery. 2013; 31: 474–479.
[31] Bora N, Parihar P, Raj N, Shetty N, Nunna B. A systematic review of the role of magnetic resonance imaging in the diagnosis and detection of neurovascular conflict in patients with trigeminal neuralgia. Cureus. 2023; 15: e44614.
[32] Wang Q-P, Bai M. Topiramate versus carbamazepine for the treatment of classical trigeminal neuralgia: a meta-analysis. CNS Drugs. 2011; 25: 847–857.
Science Citation Index (SCI)
Science Citation Index Expanded (SCIE)
BIOSIS Previews
Scopus
Cumulative Index to Nursing and Allied Health Literature (CINAHL)
Top